Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 74

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 74
---
 embarrassment. The Insider Trading Policy also prohibits all employees (including our named executives) and directors from engaging in hedging transactions, such as purchasing prepaid variable forwards, equity swaps, collars and exchange funds. Our Insider Trading Policy also prohibits the purchase or sale of Charles River securities while in possession of material, non-public information, or otherwise using such information for one’s personal benefit. Our executives and directors are permitted to enter into trading plans that are intended to comply with the requirements of Rule 10b5-1 of the Securities Exchange Act of

56

1934 so that they can prudently diversify their asset portfolios and exercise their stock options prior to their scheduled expiration dates. REPORT OF COMPENSATION COMMITTEE The Compensation Committee, composed of independent directors, has reviewed and discussed the above Compensation Discussion and Analysis (CD&A) with the Company’s management and, based on the review and discussions, recommended to Board of Directors that the CD&A be included in this Proxy Statement. The foregoing report has been furnished by the Compensation Committee. THE COMPENSATION COMMITTEE
Mr. Richard F. Wallman (Chair)
Ms. Reshema Kemps-Polanco
Mr. George E. Massaro
Ms. Virginia M. Wilson 57

EXECUTIVE COMPENSATION AND RELATED INFORMATION 2024 Summary Compensation Table The following table sets forth all of the compensation awarded to, earned by, or paid to our current named executives (our principal executive officer, our principal financial officer, and our three other highest paid executive officers) for the fiscal years ended December 28, 2024, December 30, 2023, and December 31, 2022.

| Name and Principle Position                                                         | ​ | ​ | Year |   |      |   | ​ | ​ | Salary($) |   |           |   | ​ | ​ | StockAwards($)(1) |   |           |   | ​ | ​ | OptionAwards($)(2) |   |           |   | ​ | ​ | Bonus($) |   |   |   | ​ | ​ | Non-EquityIncentivePlanCompensation($)(3) |   |         |   | ​ | ​ | Change inPensionValue andNon-qualifiedDeferredCompensationEarnings($) |   |   |   | ​ | ​ | All OtherCompensation($)(4) |   |         |   | ​ | ​ |   Total($) |   |            |   | ​ |
| James C.